DW

Doug Ward

Lumos Diagnostics Holdings Limited | Chief Executive Officer, Managing Director
Mr Ward has more than 30 years of biotech and medical technology experience at global healthcare companies including Roche, GE, Siemens, Bayer, Chiron and Hologic. During his career, Mr. Ward held executive positions where he developed and implemented novel business strategies and introduced products to the practice of medicine. Prior to joining Lumos, he served as Vice President, Strategy and Business Development at Hologic where he led a global team responsible for women's healthcare to improve clinical results. Mr. Ward also served as the CEO of Personal Genome Diagnostics (PGDx) where he led the organization's change from a clinical laboratory testing service into a functional molecular invitro diagnostics (IVD) company. He brings experience across all company functions, including Commercial Leadership, R&D, Operations, Quality, Regulatory, Service, and Support.

Company and Roles

Company
Title
Tenure
Since
LDX
Lumos Diagnostics Holdings Limited
  • Chief Executive Officer
  • Managing Director
4yrsJun 2022

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
LDX
Lumos Diagnostics Holdings Limited
02/06/266,924,331N/A20,595,000N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
LDX
Lumos Diagnostics Holdings Limited
02/06/26
Issued
3,706,331$0.105$389,164Issue of securities
LDX
Lumos Diagnostics Holdings Limited
30/10/25
Issued
22,000,000$0.205$4,510,000Issue of securities
LDX
Lumos Diagnostics Holdings Limited
05/12/24
Issued
2,743,000$0.043$117,949Issue of securities
LDX
Lumos Diagnostics Holdings Limited
18/10/23
Buy
250,000$0.087$21,645On-market trade